Knights of Columbus Asset Advisors »

Denali Therapeutics shares owned by Knights of Columbus Asset Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Knights of Columbus Asset Advisors from 13F filings

Historical chart of Knights of Columbus Asset Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Knights of Columbus Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Knights of Columbus Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 77k 21.46
2023-09-30 $787k 38k 20.63
2023-06-30 $1.1M 37k 29.51